Business

Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations

Press release – No. 14 / 2025 Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations Copenhagen, Denmark, September 24, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced the appointment of Rachel James-Owens as Vice President, Corporate Communications & Media Relations. Rachel brings over 20 years of global pharmaceut

articleZealand Pharma A/sSeptember 24, 20255/company/zealand-pharma-as-1/news/zealand-pharma-appoints-rachel-james-owens-as-vice-president-corporate-communications-and-media-relations
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations

About this update from Zealand Pharma A/s

[{"type":"image","alt":"Zealand Pharma","displaySize":"","headline":null,"caption":"Zealand Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":121,"url":"https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6gUCOEdJjLHihlE.VvDQtA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2OTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff","width":300,"height":121}},"lazy":false},{"type":"text","content":"Press release – No. 14 / 2025","length":29,"tagName":"p"},{"type":"text","content":"Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations","length":108,"tagName":"p"},{"type":"text","content":"Copenhagen, Denmark, September 24, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced the appointment of Rachel James-Owens as Vice President, Corporate Communications & Media Relations.","length":320,"tagName":"p"},{"type":"text","content":"Rachel brings over 20 years of global pharmaceutical experience across Pfizer and Novartis, spanning sales, commercial, and corporate and executive communications. Most recently, she served as Executive Director, Global Corporate Communications at Novartis Global Health & Sustainability. Prior to that, she led global executive oncology communications at Novartis and held several regional positions at Pfizer. She holds an MBA in Leadership, Culture & Coaching, and is an alum of the Corporate Affairs Leadership Academy, University of Oxford’s Saïd Business School.","length":576,"tagName":"p"},{"type":"text","content":"Adam Steensberg, Chief Executive Officer of Zealand Pharma, said:","length":65,"tagName":"p"},{"type":"text","content":"“We are delighted to welcome Rachel to Zealand Pharma at this pivotal time of accelerated growth. With a number of significant milestones ahead, Rachel’s extensive communications leadership experience will be invaluable as we balance near-term opportunities with our long-term journey to become a generational biotech.”","length":319,"tagName":"p"},{"type":"text","content":"Rachel James-Owens added:","length":25,"tagName":"p"},{"type":"text","content":"“Zealand Pharma has...

More updates from Zealand Pharma A/s

Zealand PharmaCorporate CommunicationsMedia RelationsRachel James-Owensbiotechnology companyforward-looking statementsVice PresidentNovartisforward-looking statementAdam Steensberg